Assessing corneal health after lens implantation
Official title: Corneal Endothelial Assessment After Posterior Chamber Phakic Intraocular Lens Implantation
Run by Sohag University · NCT06849375 · Data updated 2026-11-12
This study tests how putting a special lens in the eye affects the health of the cornea in young adults over time.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 35 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag, Sohag Governorate) |
| Status | Recruiting |
| Started | May 10, 2024 |
| Main results expected | December 20, 2025 |
| Study ends | December 20, 2025 |
| Registry record updated | February 27, 2025 |
| Trial ID | NCT06849375 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-35 with high myopia and sufficient anterior chamber depth.
✕Probably not a fit
Patients with previous eye diseases, surgeries, or insufficient anterior chamber depth may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the impact of phakic intraocular lens (IOL) implantation on the corneal endothelium in young adults. Using a specular microscope, researchers will measure changes in corneal endothelial cell density following the procedure. The study aims to determine whether this type of lens implantation affects corneal health over time. Participants will be monitored for endothelial cell counts to assess any potential adverse effects.
Why it matters
Potential benefit: If successful, this study could provide insights into the safety of phakic IOLs and their long-term effects on corneal health.
How similar studies have gone: While similar studies have been conducted, the specific focus on corneal endothelial assessment post-phakic IOL implantation may provide novel insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Our inclusion criteria include: adults 18-35 years of age, myopia ˃ 6 D , anterior chamber depth (ACD) 2.85 mm or greater , an endothelial cell count of ≥ 2000 cells/mm2 and stable refractive history within 0.5 diopter for 1 year. Exclusion Criteria: * anterior chamber depth from endothelium \< 2.85 mm, previous or current systemic or eye disease , surgery or trauma, pregnancy and nursing.
Where it's running
-
Sohag University Hospital
Sohag, Sohag Governorate, Egypt Recruiting
Study contacts
- Study coordinator: Noha M Abdelhameed, Resident
- Email: mnoha0421@gmail.com
- Phone: +20 01005156393
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Polishing the Descemet membrane before endothelial keratoplasty for Fuchs endothelial corneal dystrophy
This trial tests whether polishing the diseased Descemet membrane before injecting cultured endothelial cells helps improve graft adhesion and outcomes for people with Fuchs endothelial corneal dystrophy.
-
Lying on your back after DMEK: 1 day versus 5 days
This trial sees if lying on your back for five days after DMEK surgery helps the transplant stick better than lying on your back for one day for people with Fuchs endothelial corneal dystrophy or corneal failure.
-
VALIDATING the SUCCESS Score to predict need for endothelial keratoplasty after cataract surgery in Fuchs dystrophy
This study will test whether the SUCCESS Score, with corneal densitometry, can predict which people with Fuchs endothelial corneal dystrophy having cataract surgery will later need endothelial keratoplasty.
-
DT-168 for people with Fuchs endothelial corneal dystrophy who are having a corneal transplant
This study will test whether DT-168 eye drops are safe, well tolerated, and how they act in people with Fuchs endothelial corneal dystrophy who are scheduled for corneal transplant.
-
Comparing femtosecond laser-assisted versus conventional cataract surgery for people with Fuchs endothelial corneal dystrophy
This study will test whether femtosecond laser-assisted cataract surgery or conventional phacoemulsification better preserves corneal endothelial cells and vision in adults with moderate to severe Fuchs endothelial corneal dystrophy who need cataract surgery.
-
Observing outcomes of posterior lamellar keratoplasty for eye conditions
This study looks at how well two types of eye surgeries for conditions like Fuchs' dystrophy and bullous keratopathy work in helping patients see better over time.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.